Dr Reddys Laboratories Share Price Today - Live Blog for November 25, 2025

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.11% recently. As of now, this stock is actively trading at a current market price of ₹1,235.95 per share, attracting attention from investors.

The stock of Dr Reddys Laboratories Ltd is facing a -0.14% decline and is currently trading at ₹1,233.80 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.33%, signalling a challenging period. Currently trading at ₹1,237.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Demonstrating a commendable 0.01% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,240.55. In terms of valuation, the stock maintains a PE ratio of 17.8200, while the industry PE ratio stands at 33.0081.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.07%, reaching a current market price of ₹1,240.35. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd witnessed a -0.09% drop in its share price and is currently trading at ₹1,241.15. With the stock's PE at 17.8200 and the industry PE at 33.0081, investors are weighing their options.

Dr Reddys Laboratories Ltd share price has declined by -0.04%, and it's currently trading at ₹1,242.25. The stock maintains a PE of 17.8200, while the industry PE is 33.0081, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd experienced a -0.04% dip in its share price and is currently trading at ₹1,242.25. The stock has a PE ratio of 17.8200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd is facing a -0.04% decline and is currently trading at ₹1,242.25 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd witnessed a -0.03% drop in its share price and is currently trading at ₹1,244.65. With the stock's PE at 17.8200 and the industry PE at 33.0081, investors are weighing their options.

With a -0.03% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,244.65. Investors should examine the factors driving this decline. The stock's PE ratio is 17.8200, whereas the industry PE ratio stands at 33.0081.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.03% drop, and it's now trading at ₹1,244.65 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

With a -0.29% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,244.45. Investors should examine the factors driving this decline. The stock's PE ratio is 17.8200, whereas the industry PE ratio stands at 33.0081.

Dr Reddys Laboratories Ltd shares saw a -0.04% decrease, reaching a current market price of ₹1,248.10. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.8200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price surged by 0.06%. With its current market price standing at ₹1,248.75 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd suffered a -0.13% decline, and it currently trades at ₹1,248.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's share price rallied by 0.60%, reaching the current market price of ₹1,249.25. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd experienced a substantial 0.14% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,242.00, making it an appealing option for investors.

Dr Reddys Laboratories Ltd share price has declined by -0.09%, and it's currently trading at ₹1,239.40. The stock maintains a PE of 17.8200, while the industry PE is 33.0081, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's share price rallied by 0.16%, reaching the current market price of ₹1,240.00. This surge is indicative of the stock's recent positive performance.

With a -0.11% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,239.85. Investors should examine the factors driving this decline. The stock's PE ratio is 17.8200, whereas the industry PE ratio stands at 33.0081.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.11% drop, and it's now trading at ₹1,239.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd observed a -0.33% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,241.15. The stock has a PE ratio of 17.8200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

With a remarkable 0.04% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,244.45. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.8200, while the industry's PE ratio is 33.0081.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.07%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,243.90 per share.

With a -0.06% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,242.95. Investors should examine the factors driving this decline. The stock's PE ratio is 17.8200, whereas the industry PE ratio stands at 33.0081.